291 related articles for article (PubMed ID: 9750045)
1. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
[TBL] [Abstract][Full Text] [Related]
2. Quality control in cytopathology applied to screening for cervical carcinoma.
Marsan C
Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
[TBL] [Abstract][Full Text] [Related]
3. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
[No Abstract] [Full Text] [Related]
4. [Practice guidelines in Pathologic Anatomy and Cytology. Document prepared by the French Association of Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP). Commission No. 4: organization and functioning of Pathologic Anatomy and Cytology].
Saint-André JP; Donzel JP; Anger E; Chatelet F; Cochand-Priollet B; de Graeve P; Gérard F; Hassoun J; Hénin D; Marsan C; Martin E; Martin MJ; Menchon C; Muller B; Parache M; Rey C; Sevestre H; Voigt JJ; Ngoc PH; Zerat L
Ann Pathol; 1998 Jul; 18(3):227-36. PubMed ID: 9750046
[No Abstract] [Full Text] [Related]
5. [Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"].
Calvache AE
Biomedica; 2009 Mar; 29(1):161-2; author reply 162-3. PubMed ID: 19753849
[No Abstract] [Full Text] [Related]
6. [Cervical cancer screening in the Bas-Rhin. Evaluation of four and a half years of the EVE campaign].
Fender M; Schaffer P; Dellenbach P
Sante Publique; 2000 May; 12 Spec No():11-20. PubMed ID: 10989625
[TBL] [Abstract][Full Text] [Related]
7. [Recommendations from the experimental sites for implementing organized cervical cancer screening in France].
Baudier F; Schapman S; Giordanella JP
Sante Publique; 2000 May; 12 Spec No():71-88. PubMed ID: 10989630
[No Abstract] [Full Text] [Related]
8. Quality assurance in cervical cytopathology.
Light AM
Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
[No Abstract] [Full Text] [Related]
9. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
[TBL] [Abstract][Full Text] [Related]
10. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
Greer BE
Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
[TBL] [Abstract][Full Text] [Related]
11. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
[TBL] [Abstract][Full Text] [Related]
12. Organisation of cervical cytology screening in Croatia: past, present and future.
Pajtler M; Audy-Jurković S; Kardum-Skelin I; Mahovlić V; Mozetic-Vrdoljak D; Ovanin-Rakić A
Coll Antropol; 2007 Apr; 31 Suppl 2():47-54. PubMed ID: 17598505
[TBL] [Abstract][Full Text] [Related]
13. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
[TBL] [Abstract][Full Text] [Related]
14. [An operative model: verification of the quality of the screening Pap test ].
Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
[No Abstract] [Full Text] [Related]
15. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology.
Arbyn M; Herbert A; Schenck U; Nieminen P; Jordan J; Mcgoogan E; Patnick J; Bergeron C; Baldauf JJ; Klinkhamer P; Bulten J; Martin-Hirsch P
Cytopathology; 2007 Jun; 18(3):133-9. PubMed ID: 17573762
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening from the public health perspective.
Steiner C
Acta Cytol; 1989; 33(4):471-4. PubMed ID: 2750437
[TBL] [Abstract][Full Text] [Related]
17. [Cervical cancer screening. False negative smears].
Vassilakos P; De Marval F; Muñoz M
Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
[No Abstract] [Full Text] [Related]
18. Quality assessment in the age of machine-aided cervical cytology screening.
Renshaw AA
Cancer; 2004 Dec; 102(6):345-7. PubMed ID: 15540251
[No Abstract] [Full Text] [Related]
19. [Cytological history of cases of invasive cervical cancer diagnosed in France in 2006].
Boulanger JC; Fauvet R; Urrutiaguer S; Drean Y; Sevestre H; Ganry O; Bergeron C; Gondry J
Gynecol Obstet Fertil; 2007 Sep; 35(9):764-71. PubMed ID: 17765001
[TBL] [Abstract][Full Text] [Related]
20. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
